| Product Code: ETC11977710 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Despite the high Herfindahl-Hirschman Index (HHI) indicating concentrated market shares, Ireland continued to rely on imports of dendritic cell cancer vaccines in 2024. The top exporting countries to Ireland were the USA, UK, Germany, Metropolitan France, and Serbia. The compound annual growth rate (CAGR) for the period 2020-2024 was -4.18%, with a significant decline in growth rate from 2023 to 2024 at -30.16%. This suggests a challenging market environment for dendritic cell cancer vaccines in Ireland, prompting a need for strategic considerations to stimulate growth and diversify import sources.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Dendritic Cell Cancer Vaccines Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Dendritic Cell Cancer Vaccines Market - Industry Life Cycle |
3.4 Ireland Dendritic Cell Cancer Vaccines Market - Porter's Five Forces |
3.5 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.7 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
4 Ireland Dendritic Cell Cancer Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Ireland Dendritic Cell Cancer Vaccines Market Trends |
6 Ireland Dendritic Cell Cancer Vaccines Market, By Types |
6.1 Ireland Dendritic Cell Cancer Vaccines Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Cancer Type, 2021 - 2031F |
6.1.3 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Lung, 2021 - 2031F |
6.1.4 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Breast, 2021 - 2031F |
6.1.5 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Melanoma, 2021 - 2031F |
6.2 Ireland Dendritic Cell Cancer Vaccines Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.2.3 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3 Ireland Dendritic Cell Cancer Vaccines Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Online, 2021 - 2031F |
6.4 Ireland Dendritic Cell Cancer Vaccines Market, By Delivery Method |
6.4.1 Overview and Analysis |
6.4.2 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4.3 Ireland Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Intravenous, 2021 - 2031F |
7 Ireland Dendritic Cell Cancer Vaccines Market Import-Export Trade Statistics |
7.1 Ireland Dendritic Cell Cancer Vaccines Market Export to Major Countries |
7.2 Ireland Dendritic Cell Cancer Vaccines Market Imports from Major Countries |
8 Ireland Dendritic Cell Cancer Vaccines Market Key Performance Indicators |
9 Ireland Dendritic Cell Cancer Vaccines Market - Opportunity Assessment |
9.1 Ireland Dendritic Cell Cancer Vaccines Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Ireland Dendritic Cell Cancer Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.3 Ireland Dendritic Cell Cancer Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Ireland Dendritic Cell Cancer Vaccines Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
10 Ireland Dendritic Cell Cancer Vaccines Market - Competitive Landscape |
10.1 Ireland Dendritic Cell Cancer Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Ireland Dendritic Cell Cancer Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |